Direct providership by American Academy of Addiction Psychiatry
Adam Bisaga, MD | Professor of Psychiatry, Columbia University Medical Center, New York, NY
This introductory module is a case-based discussion of the general approach to evaluation and treatment of patients presenting with problematic opioid use. Benefits and limitations of available medications and differences between them are described. An approach to choosing first and second line treatments is also presented.
- Describe the components of evaluation for medication assisted treatment
- Discuss the range of treatment goals for patients with OUD
- Identify the FDA-approved pharmacological treatments for OUD
- Demonstrate an understanding of the benefits and limitations of all available treatments and differences between them
- Describe the different first and second-line approaches to treat OUD and the process of shared decision making
American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs may claim a maximum of 1 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Method of participation in the learning process
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.